Abstract:BACKGROUND: Hypoxia-inducible factor-1 alpha (HIF-1 alpha) plays an important role in tumour progression and metastasis through activation of many target genes that are especially involved in pivotal aspects of cancer biology. However, the prognostic role of HIF-1 alpha has been controversial in primary patients with lung cancer. This meta-analysis was performed to systematically evaluate whether HIF-1 alpha expression is associated with the clinical outcomes in lung cancer patients.METHODS: We retrieved relevant articles from Cochrane library, PubMed, EMbase, CNKI, CBM, VIP and Wan Fang Databases from inception to May 2012. Studies were selected using specific inclusion and exclusion criteria. A systematic review and meta-analysis was performed on the association between HIF-1 alpha expression and clinical outcomes in lung cancer patients. All analyses were performed using the Revman 5.1 software.RESULTS: A total of 30 studies were identified as eligible for the systematic review and meta-analysis. The expression of HIF-1 alpha was significantly higher than those in normal lung tissue; and III-IV stage, lymph node metastasis, poorly differentiation, squamous cell carcinoma and small cell lung cancer (SCLC) were significantly higher than those in I-II stage, no lymph node metastasis, well differentiation, adenocarcinomas and non small cell lung cancer (NSCLC), respectively (odds ratio (OR) = 19.00, 95% confidence interval (CI):12.12-29.78, p<0.00001; OR = 0.23, 95% CI:0.14-0.36, p<0.00001; OR = 3.72, 95% CI:2.38-5.80, p<0.00001; OR = 0.47, 95% CI:0.31-0.70, p<0.00002, OR = 0.24, 95% CI:0.07-0.77, p = 0.02; OR = 0.78, 95% CI:0.63-0.98, p = 0.03). VEGF and CA IX positive expression in HIF-1 alpha positive tumour tissues were significantly higher than those in HIF-1 alpha negative tumour tissues, respectively (OR = 3.23, 95% CI: 1.90-5.46, p<0.0001; OR = 3.84, 95% CI: 2.10-7.03, p<0.0001). The positive HIF-1 alpha tumour tissues of patients had lower 5-year survival rates (OR = 0.13, 95% CI: 0.03-0.47, p = 0.002) and overall survival (relative risk (RR) = 1.68, 95% CI: 1.12-2.50, p = 0.01).CONCLUSIONS: HIF-1 alpha is related to a differing degree of lung cancer cell, lymph node metastasis, post-operative survival time and histology (NSCLC vs. SCLC, adenocarcinomas vs. squamous cell carcinoma). HIF-1 alpha, which combines other proteins, such as vascular endothelial growth factor (VEGF) or CA IX, might serve as important parameters in evaluating biological behaviour and prognosis of lung cancer; it will be of benefit to clinical treatment and prognostic evaluation.

Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer

Expression of Glucose Transporter-1, Hypoxia Inducible Factor-1Α and Beclin-1 in Head and Neck Cancer and Their Implication.

Oxia Inducible Factor 1α and Hypoxia Inducible Factor 2α Distinct and Functionally Overlapping Roles in R L Squamous Cell Carcinoma

Hypoxia Inducible Factor 1 Alpha And Hypoxia Inducible Factor 2 Alpha Play Distinct And Functionally Overlapping Roles In Oral Squamous Cell Carcinoma

HIF-1 and HIF-2 Play Distinct and Functionally Overlapping Roles in Oral Squamous Cell Carcinoma

Meta-analysis of Immunohistochemical Expression of Hypoxia Inducible Factor-1Α As a Prognostic Role in Gastric Cancer.

Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head-Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy.

Prognostic implications of HIF-1α expression in anal squamous cell carcinoma treated with intensity-modulated radiotherapy (IMRT)

Hypoxia-inducible factor-2 alpha (HIF-2α) target activation and clinical outcomes in 942 patients with clear cell renal cell carcinoma.

Hypoxia Inducible Factor-Alpha Expression Correlates with Vascular Endothelial Growth Factor-C Expression and Lymphangiogenesis/angiogenesis in Oral Squamous Cell Carcinoma.

Overexpression Of Hif-1 Alpha Indicates A Poor Prognosis In Tongue Carcinoma And May Be Associated With Tumour Metastasis

The Expression Of Hypoxia-Inducible Factor-1 Alpha And Its Clinical Significance In Lung Cancer: A Systematic Review And Meta-Analysis

The Prognostic Value of HIF-1α and VEGF Expression in Hypopharyngeal Squamous Cell Carcinoma

Targeting HIF-1α/NOTCH1 pathway eliminates CD44+ cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma

Hypoxia-inducible Factor-1Α Overexpression Indicates Poor Clinical Outcomes in Tongue Squamous Cell Carcinoma.

Hypoxia Inducible Factor-1α and Vascular Endothelial Growth Factor Expression are Associated with a Poor Prognosis in Patients with Nasopharyngeal Carcinoma Receiving Radiotherapy with Carbogen and Nicotinamide

The Interplay of HIF1A, DNA Methylation, and Prolyl Hydroxylases in Head and Neck Squamous Cell Carcinoma

Lymphocyte Infiltration Determines the Hypoxia-Dependent Response to Definitive Chemoradiation in Head-and-Neck Cancer: Results from a Prospective Imaging Trial

Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models

The Prognostic Value of Hypoxia-Inducible Factor-1Α in Advanced Cancer Survivors: a Meta-Analysis with Trial Sequential Analysis.

Hypoxia-mediated Activation of Hypoxia-Inducible Factor-1Α in Head and Neck Squamous Cell Carcinoma: A Review